|
Orthologous residues
|
|
hnRNP C1/C2 (human): Y57‑p, hnRNP C1/C2 iso2 (human): Y57‑p, hnRNP C1/C2 iso4 (human): Y57‑p, hnRNP C1/C2 (mouse): Y57‑p, hnRNP C1/C2 iso2 (mouse): Y57‑p, hnRNP C1/C2 (rat): Y57‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
BEAS-2B (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
uPA
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
RNA
|
|
Induces
|
protein stabilization
|
|
far-Western
|
|
|
Comments:
Northwestern analysis, RNA stabilization
|